Related Experiment Video
Updated: Oct 6, 2025

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
6.8K
Additional preconditioning program for bariatric surgery: Any benefits? A large cohort study.
Roos G F M van der Ven1, Rien de Vos2, Yentl Lodewijks3
1Department of Dietetics, Obesity Center Catharina Hospital, Eindhoven, The Netherlands.
Clinical Obesity
|January 18, 2022
Summary
An additional preconditioning program (APP) before bariatric surgery did not improve patient outcomes. This study found no significant benefits, suggesting current care pathways are equally effective without the added program.
Area of Science:
- Bariatric Surgery
- Clinical Outcomes
- Health Resource Management
Background:
- Additional preconditioning programs (APP) are resource-intensive for bariatric surgery patients.
- Evidence supporting the effectiveness of APPs is limited and inconsistent.
- This study evaluates APP's impact on outcomes for vulnerable patients undergoing bariatric surgery.
Purpose of the Study:
- To determine the effectiveness of an additional preconditioning program (APP) in bariatric surgery.
- To compare outcomes between vulnerable patients with and without an APP.
- To assess the impact of APP on weight loss, comorbidities, and adherence.
Main Methods:
- Retrospective, single-centre cohort study with a before-and-after design.
- Compared vulnerable patients who received an APP (Sept 2017-Mar 2018) with those who did not (Sept 2018-Mar 2019).
- Key endpoints included % total weight loss (%TWL), bodyweight, comorbidity evolution, protein intake, and no-show rates.
Main Results:
- The group without APP showed statistically significant better %TWL at 7 and 12 months postoperatively.
- The comparator group (no APP) also had significantly lower bodyweight at 12 months.
- Differences in comorbidity evolution, protein intake, and no-shows favored the group without APP.
Conclusions:
- An additional preconditioning program (APP) was not superior to standard care in this cohort.
- Statistically significant differences observed were small, questioning clinical relevance.
- A bariatric surgery care pathway without an APP appears to be at least as effective as one with it.
Related Concept Videos
Drug Dosing: Obese Patients
8
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
8
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
6
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
6

